218
Participants
Start Date
June 28, 2012
Primary Completion Date
July 31, 2013
Study Completion Date
September 18, 2013
LY2951742
Placebo
Neurology & Headache Treatment Center, McLean
PMG Research of Winston-Salem, Winston-Salem
PharmQuest, Greensboro
Florida Clinical Research Center LLC, Maitland
Accelovance, Inc, Melbourne
Broward Research Group, Pembroke Pines
Neurology Clinical Research Inc, Sunrise
Renstar Medical Research, Ocala
Nashville Neuroscience Group, Nashville
ClinSearch, Chattanooga
PMG Research of Bristol, Bristol
Westside Family Medical Center, PC, Kalamazoo
Ryan Headache Center, St. John's Mercy Medical Group, Chesterfield
Clinvest, A Division of Banyan Group, Inc., Springfield
Prarie Fields Medicine/Clinical Research Advantage, Fremont
COR Clinical Research, LLC, Oklahoma City
FutureSearch Trials of Dallas, Dallas
Clinical Trial Network (CTN Texas), Houston
FutureSearch Trials of Neurology and Sleep Lab, Austin
Neurology Studies of Austin, A Division of DermResearch Inc., Austin
Radiant Research - Denver, Denver
Arizona Research Center, Phoenix
Neurological Physicians of Arizona / Clinical Research Advantage, Gilbert
Mayo Foundation for Medical Education and Research - Mayo Clinic, Scottsdale
James Meli DO Ltd (Clinical Research Advantage), Henderson
Clinical Research Advantage, Henderson
California Medical Clinic for Headache Inc, Santa Monica
PRI Los Alamitos, Los Alamitos
Collaborative Neuroscience Network Inc., Long Beach
PRI Encino, Encino
Medical Center for Clinical Research, San Diego
Artemis Institute for Clinical Research, San Diego
Allergy and Asthma Specialists Medical Group, Huntington Beach
PRI Newport Beach, Newport Beach
San Francisco Clinical Research Center, San Francisco
University of California, San Francisco (UCSF) Medical Center - Headache Center, San Francisco
MedVadis Research, Watertown
Eli Lilly and Company
INDUSTRY